2019
DOI: 10.1002/ange.201903465
|View full text |Cite
|
Sign up to set email alerts
|

Activation of a Non‐Heme FeIII‐OOH by a Second FeIII to Hydroxylate Strong C−H Bonds: Possible Implications for Soluble Methane Monooxygenase

Abstract: Non-heme iron oxygenases contain either monoiron or diiron active sites,and the role of the second iron in the latter enzymes is atopic of particular interest, especially for soluble methane monooxygenase (sMMO). Herein we report the activation of anon-heme Fe III -OOH intermediate in asynthetic monoiron system using Fe III (OTf) 3 to form ah igh-valent oxidant capable of effecting cyclohexane and benzene hydroxylation within seconds at À40 8 8C. Our results showt hat the second iron acts as aL ewis acid to ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 34 publications
(88 reference statements)
0
2
0
Order By: Relevance
“…Nonheme diiron monooxygenases constitute a big family of metalloenzymes that are widely involved in oxidative metabolism and biosynthesis. One superfamily of nonheme diiron monooxygenases is the bacterial multicomponent monooxygenases (BMMs). Upon O 2 activation, these enzymes are able to perform a panoply of oxidative transformations. For instance, soluble methane monooxygenase (sMMO) is capable of oxidizing the C–H bond of methane at ambient temperature and pressure, while N-oxygenases AurF and CmlI are able to carry out the six-electron oxidation of aminoarenes to nitroarenes, a key step in the biosynthesis of antibiotics. Among the mostly studied nonheme diiron monooxygenases, BMMs require additional electrons from external reductants to reduce Fe­(III)­Fe­(III) to Fe­(II)­Fe­(II), which is necessary for the initiation of oxygen activation. ,,,, Unlike BMMs, myo-inositol oxygenase (MIOX) catalyzes the oxygen activation and conversion of myo-inositol (MI) to d -glucuronic acid (GlcUA) in the absence of additional reductants, which thus represents a noncanonical nonheme diiron monooxygenase. This catalytic transformation is also the first step in the catabolism of MI, which is the sugar backbone of inositol phosphates and phosphoinositides and is associated with an array of diabetic and metabolic diseases. …”
Section: Introductionmentioning
confidence: 99%
“…Nonheme diiron monooxygenases constitute a big family of metalloenzymes that are widely involved in oxidative metabolism and biosynthesis. One superfamily of nonheme diiron monooxygenases is the bacterial multicomponent monooxygenases (BMMs). Upon O 2 activation, these enzymes are able to perform a panoply of oxidative transformations. For instance, soluble methane monooxygenase (sMMO) is capable of oxidizing the C–H bond of methane at ambient temperature and pressure, while N-oxygenases AurF and CmlI are able to carry out the six-electron oxidation of aminoarenes to nitroarenes, a key step in the biosynthesis of antibiotics. Among the mostly studied nonheme diiron monooxygenases, BMMs require additional electrons from external reductants to reduce Fe­(III)­Fe­(III) to Fe­(II)­Fe­(II), which is necessary for the initiation of oxygen activation. ,,,, Unlike BMMs, myo-inositol oxygenase (MIOX) catalyzes the oxygen activation and conversion of myo-inositol (MI) to d -glucuronic acid (GlcUA) in the absence of additional reductants, which thus represents a noncanonical nonheme diiron monooxygenase. This catalytic transformation is also the first step in the catabolism of MI, which is the sugar backbone of inositol phosphates and phosphoinositides and is associated with an array of diabetic and metabolic diseases. …”
Section: Introductionmentioning
confidence: 99%
“…One superfamily of metalloenzymes can utilize non-heme diiron active sites for O 2 activation and reductions . These non-heme diiron enzymes catalyze many types of reactions, such as the challenging C–H activations occurring in sMMO, BesC, , UndA, PtmU3, and Δ9 Desaturase, epoxidation of double bond occurring in BoxB, , N-oxygenation occurring in AurF and CmlI, as well as N-hydroxylation occurring in SznF. …”
Section: Introductionmentioning
confidence: 99%